| Molecule |
Presentation |
Status |
Therapeutic Area |
| Alendronic acid |
70 mg x 4 tablets |
MA and Dossier |
FOR THE TREATMENT OF BONE DISEASE - BISPHOSPHONATE |
| 70 mg x 12 tablets |
MA and Dossier |
| Amoxicillin |
1 g 12 tablets |
MA and Dossier |
ANTIBACTERIAL FOR SYSTEMIC USE - PENICILLIN |
| Amoxicillin and clavulanic acid |
875 + 125 mg tablets and sachets |
MA and Dossier |
ANTIBACTERIAL FOR SYSTEMIC USE - PENICILLIN IN ASSOCIATION |
| pediatric sachets |
Under development |
| Atorvastatin |
10 mg x 30 tablets |
MA and Dossier |
MODIFYING SUBSTANCE OF LIPIDS -
HMG-CoA REDUCTASE INHIBITOR - (STATIN) |
| 20 mg x 30 tablets |
MA and Dossier |
| 40 mg x 30 tablets |
MA and Dossier |
| 80 mg x 30 tablets |
MA and Dossier |
| Calcium Levofolinate |
7,5 mg x 10 tablets |
Under development |
THERAPEUTIC PRODUCT - DETOXIFYING SUBSTANCE FOR ANTINEOPLASTIC TREATMENTS - ANTIDOTE |
| 4 mg x 30 tablets |
Under development |
| Calcium Levofolinate Lyophilized |
25 mg vial |
MA and Dossier |
THERAPEUTIC PRODUCT - DETOXIFYING SUBSTANCE FOR ANTINEOPLASTIC TREATMENTS -ANTIDOTE |
| 100 mg vial |
MA and Dossier |
| 175 mg vial |
MA and Dossier |
| Calcium Levofolinate solution |
25 mg/2,5 ml vial |
MA and Dossier |
THERAPEUTIC PRODUCT - DETOXIFYING SUBSTANCE FOR ANTINEOPLASTIC TREATMENTS -ANTIDOTE |
| 50 mg/ 5 ml vial |
MA and Dossier |
| 100 mg/10 ml vial |
MA and Dossier |
| 175 mg/17,5 ml vial |
MA and Dossier |
| Cefazolina |
1000 mg/4 ml powder and solvent for injectable solution i.m. |
MA and Dossier |
ANTIBACTERIAL FOR SYSTEMIC USE - CEPHALOSPORINE OF FIRST GENERATION |
| Ceftazidima |
1 g/3 ml powder and solvent for injectable solution i.m. |
MA and Dossier |
ANTIBACTERIAL FOR SYSTEMIC USE - THIRD-GENERATION CEPHALOSPORINE |
| 1 g /10 ml powder and solvent for injectable solution e.v. |
MA and Dossier |
| 2 g powder for solution infusion |
MA and Dossier |
| Ceftriaxone |
250 mg/ 2 ml - powder and solvent for injectable solution i.m. |
MA and Dossier |
ANTIBACTERIAL FOR SYSTEMIC USE - THIRD-GENERATION CEPHALOSPORINE |
| 500 mg/ 2 ml - powder and solvent for injectable solution i.m. |
MA and Dossier |
| 1 gr/3,5 ml - powder and solvent for injectable solution i.m. |
MA and Dossier |
| 1 g / 10 ml powder and solvent for injectabble solution e.v. |
MA and Dossier |
| 2 g powder for solution for infusion |
MA and Dossier |
| Cilostazole |
100 mg x 28 tablets |
MA and Dossier |
ANTITHROMBOTIC
PLASTIC ANTI-AGING |
| Ciprofloxacin |
250 mg x 10 tablets |
MA and Dossier |
ANTIBACTERIALS FOR SYSTEMIC USE - KINOLONIC ANTIBACTERIALS |
| 500 mg x 6 tablets |
MA and Dossier |
| 750 mg x 12 tablets |
MA and Dossier |
| Citalopram drops |
40 mg/ml |
Dossier |
ANTIDEPRESSANT -SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI) |
| Clodronic Acid + lidocaine |
100 mg / 3,3 ml 6 vials |
Dossier |
FOR THE TREATMENT OF BONE DISEASE - BISPHOSPHONATE |
| 200 mg/ 4 ml 3 vials |
Dossier |
| Desketoprofene |
25 mg 20 tablets |
MA and Dossier |
ANTI-INFLAMMATORY AND ANTIREHUMATIC, NOT STEROID |
| 25 mg oral solution stick pack |
MA and Dossier |
| Dutasteride |
0,5 mg x 30 capsules |
MA and Dossier |
DRUG USED IN BENIGNA PROSTATIC HYPERTROPHY |
| Escitalopram drops |
20 mg /ml - bottle 15 ml |
MA and Dossier |
ANTIDEPRESSANT -
SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRI) |
| Finasteride |
1 mg x 28 tablets |
MA and Dossier |
DRUG USED FOR STATES OF ANDROGENETIC ALOPECIA IN MEN |
| 5 mg x 15 tablets |
MA and Dossier |
DRUG USED IN BENIGNA PROSTATIC HYPERTROPHY |
| Fosfomycin Trometamol |
3 g granular for solution - 2 sachets |
MA and Dossier |
ANTIBACTERIAL FOR SYSTEMIC USE |
| Furosemide |
25 mg x 30 tablets |
Dossier |
DIURETIC - DIURETIC FOR HIGHER DIURETIC ACTION -
NON-ASSOCIATED SULPHONAMID |
| 500 mg x 20 tablets |
Dossier |
| Ibandronate |
150 mg x 3 tablets |
MA and Dossier |
FOR THE TREATMENT OF BONE DISEASE - BISPHOSPHONATE |
| Manidipine |
10 mg x 28 tablets |
MA and Dossier |
CALCIUM-ANTAGONIST |
| 20 mg x 28 tablets |
MA and Dossier |
| Metformina |
500 mg, 30-50 tablets |
Under registration |
FOR THE TREATMENT OF TYPE 2 DIABETES - BIGUANIDE |
| 850 mg, 30-40 tablets |
Under registration |
| 850 mg, 40 tablets |
Under registration |
| 1000 mg, 60 tablets |
Under registration |
| Montelukast |
10 mg x 28 tablets |
MA and Dossier |
FOR OBSTRUCTIVE AIRWAY SYNDROMES FOR SYSTEMIC USE - ANTAGONIST OF LEUCOTRIENIC RECEPTORS |
| 4 mg x 28 tablets |
MA and Dossier |
| 5 mg x 28 tablets |
MA and Dossier |
| Nebivolole |
5 mg x 28 tablets |
MA and Dossier |
SELECTIVE BETA BLOCKER -
FOR THE TREATMENT OF HYPERTENSION |
| Omeprazole |
10 mg x 14-28 capsules |
MA and Dossier |
FOR DISORDERS RELATED TO ACID SECRETION - FOR THE TREATMENT OF PEPTIC ULCER AND GASTROESOGACEOUS REFLUX DISEASE -
PROTON-PUMP INHIBITORS (PPIs) |
| 20 mg x 14-28 capsules |
MA and Dossier |
| 40 mg x 14-28 capsules |
MA and Dossier |
| Pantoprazole (OTC) |
20 mg x 7 - 14 tablets |
MA and Dossier |
FOR DISORDERS RELATED TO ACID SECRETION - FOR THE TREATMENT OF PEPTIC ULCER AND GASTROESOGACEOUS REFLUX DISEASE -
PROTON-PUMP INHIBITORS (PPIs) |
| Paroxetine drops |
10 mg/ml oral drops, solution |
Under registration |
ANTIDEPRESSANT -SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI) |
| Prednisone |
5 mg x 20 tablets |
MA and Dossier |
SYSTEMIC CORTICOSTEROID - GLUCOCORTICOID |
| 5 mg x 10 tablets |
MA and Dossier |
| 25 mg x 10 tablets |
MA and Dossier |
| VITAMIN D3 |
soft gel capsules: 10.000 U.I. |
Under registration |
VITAMIN D |
| soft gel capsules: 25.000 U.I. |
Under registration |
| soft gel capsules: 50.000 U.I. |
Under registration |
| soft gel capsules: 100.000 U.I. |
Under registration |
| injectable: 100.000 U.I. |
Under registration |
| injectable: 300.000 U.I. |
Under registration |
